CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant

NCT03560752 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Accelerated Phase CML, BCR-ABL1 Positive
Acute Lymphoblastic Leukemia in Remission
Acute Myeloid Leukemia in Remission
Chronic Lymphocytic Leukemia
Chronic Phase CML, BCR-ABL1 Positive
Cytomegalovirus Positive
Donor
Hematopoietic Cell Transplant Recipient
Hodgkin Lymphoma
Myelodysplastic Syndrome
Myelodysplastic/Myeloproliferative Neoplasm
Non-Hodgkin Lymphoma
Myelofibrosis
Hematopoietic and Lymphoid Cell Neoplasm

Interventions

BIOLOGICAL: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine

Sponsor

City of Hope Medical Center

Collaborators

[object Object]